Class Action Notice for Nano-X Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Globenewswire
- Class Action Initiation: The Portnoy Law Firm has advised investors of Nano-X Imaging Ltd. about a class action lawsuit for those who purchased securities between March 31, 2025, and April 17, 2026, with a deadline of August 11, 2026, for filing a lead plaintiff motion to protect their legal rights.
- Financial Misrepresentation Allegations: The complaint alleges that Nano-X made false statements regarding operational efficiency and product demand, misleading investors about the company's financial health, particularly highlighted by a reported Q4 net loss of $33.4 million due to a $17.5 million impairment charge from restructuring.
- Executive Departure Impact: The lawsuit also notes that CFO Ran Daniel will resign effective July 31, 2026, indicating instability in management and operations, which could further undermine investor confidence and the company's future financial performance.
- Restructuring and Efficiency Shift: Nano-X acknowledged in its financial report the need to transition to a more efficient outsourced production model to better align with current and anticipated demand, a shift that may lead to significant restructuring and impairment charges, increasing operational uncertainty going forward.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NNOX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NNOX
Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.720
Low
7.00
Averages
7.00
High
7.00
Current: 1.720
Low
7.00
Averages
7.00
High
7.00
About NNOX
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Notice for Nano-X Investors
- Class Action Initiation: The Portnoy Law Firm has advised investors of Nano-X Imaging Ltd. about a class action lawsuit for those who purchased securities between March 31, 2025, and April 17, 2026, with a deadline of August 11, 2026, for filing a lead plaintiff motion to protect their legal rights.
- Financial Misrepresentation Allegations: The complaint alleges that Nano-X made false statements regarding operational efficiency and product demand, misleading investors about the company's financial health, particularly highlighted by a reported Q4 net loss of $33.4 million due to a $17.5 million impairment charge from restructuring.
- Executive Departure Impact: The lawsuit also notes that CFO Ran Daniel will resign effective July 31, 2026, indicating instability in management and operations, which could further undermine investor confidence and the company's future financial performance.
- Restructuring and Efficiency Shift: Nano-X acknowledged in its financial report the need to transition to a more efficient outsourced production model to better align with current and anticipated demand, a shift that may lead to significant restructuring and impairment charges, increasing operational uncertainty going forward.
See More
Class Action Lawsuit Filed Against Nano-X Imaging Ltd.
- Class Action Initiation: Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025, and April 17, 2026, allowing potential lead plaintiffs to apply by August 11, 2026, for compensation.
- Lawsuit Allegations: The lawsuit claims that Nano-X made false statements regarding operational efficiency and product demand, resulting in significant investor losses when the truth emerged, highlighting a misalignment between production capabilities and market needs.
- Cost Structure: Investors joining the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, which lowers the barrier for affected investors to participate in the lawsuit.
- Firm's Reputation: Rosen Law Firm is recognized for its success in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resourcefulness in handling such cases.
See More
Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
- Class Action Initiation: Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey, covering securities transactions from March 31, 2025, to April 17, 2026, seeking damages for violations of federal securities laws by company executives.
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a Q4 net loss of $33.4 million, including a $17.5 million impairment charge, highlighting significant issues in production efficiency and cost management.
- Stock Price Plunge: Following the earnings release, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting market pessimism regarding the company's future prospects.
- Executive Changes: The resignation of CFO Ran Daniel effective July 31, 2026, indicates management instability as the company navigates operational challenges and restructuring efforts.
See More
Class Action Lawsuit Reminder Against Nano-X Imaging Ltd.
- Class Action Notification: The Schall Law Firm is reminding investors of a class action lawsuit against Nano-X Imaging Ltd. for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between March 31, 2025, and April 17, 2026.
- False Statement Allegations: The complaint alleges that Nano-X made false and misleading statements regarding product demand and operational efficiency, resulting in significant investor losses once the truth was revealed.
- Cash Flow Issues: The company is experiencing increased cash burn due to misalignment with customer demands, exacerbating its financial difficulties and negatively impacting market reputation and investor confidence.
- Legal Consultation Opportunity: The Schall Law Firm encourages affected investors to contact them before August 11, 2026, to participate in the lawsuit and seek compensation for losses, emphasizing that investors are not represented until the class is certified.
See More
Nano-X Imaging Under Investigation Following Significant Losses and Stock Drop
- Financial Loss Disclosure: On April 20, 2026, Nano-X Imaging reported a net loss of $33.4 million in its Q4 2025 financial results, primarily due to a $17.5 million impairment charge related to restructuring at its Korean chip manufacturing facility, highlighting significant financial strain and operational challenges.
- Executive Departure Impact: The announcement of the CFO's resignation raises concerns about the company's future financial management capabilities, potentially undermining investor confidence and adversely affecting stock performance.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price plummeted by $0.69, or 24.4%, closing at $2.16 per share, reflecting a strong investor reaction to the company's financial health, which may lead to more investors seeking legal recourse.
- Legal Investigation Initiated: The Law Offices of Howard G. Smith have announced an investigation into potential violations of securities laws by Nano-X, aiming to provide legal support for affected investors, indicating that the company faces increasing legal risks that could exacerbate market uncertainty.
See More
Reminder of Shareholder Class Action Lawsuits
- ADMA Lawsuit Details: The class action lawsuit against ADMA Biologics, Inc. alleges that the company made materially false or misleading statements between August 9, 2024, and March 25, 2026, leading to investor losses, with a deadline of August 10, 2026, for investors to apply as lead plaintiffs to protect their rights.
- Erasca Case Overview: The shareholder class action against Erasca, Inc. claims that the company failed to disclose material facts related to ERAS-0015 from January 14, 2025, to April 26, 2026, with a similar deadline of August 10, 2026, for investors to seek lead plaintiff status for legal recourse.
- Nano-X Litigation Insights: The lawsuit against Nano-X Imaging Ltd. alleges false statements regarding operational efficiency and cash burn from March 31, 2025, to April 17, 2026, with a deadline of August 11, 2026, for investors to apply as lead plaintiffs to safeguard their interests.
- Law Firm Credentials: Holzer & Holzer, LLC, recognized as a top-rated securities litigation firm from 2021 to 2025, focuses on vigorous representation of shareholders, having recovered hundreds of millions for victims of fraud and corporate misconduct since its inception in 2000.
See More
Class Action Notice for Nano-X Investors
- Class Action Initiation: The Portnoy Law Firm has advised investors of Nano-X Imaging Ltd. about a class action lawsuit for those who purchased securities between March 31, 2025, and April 17, 2026, with a deadline of August 11, 2026, for filing a lead plaintiff motion to protect their legal rights.
- Financial Misrepresentation Allegations: The complaint alleges that Nano-X made false statements regarding operational efficiency and product demand, misleading investors about the company's financial health, particularly highlighted by a reported Q4 net loss of $33.4 million due to a $17.5 million impairment charge from restructuring.
- Executive Departure Impact: The lawsuit also notes that CFO Ran Daniel will resign effective July 31, 2026, indicating instability in management and operations, which could further undermine investor confidence and the company's future financial performance.
- Restructuring and Efficiency Shift: Nano-X acknowledged in its financial report the need to transition to a more efficient outsourced production model to better align with current and anticipated demand, a shift that may lead to significant restructuring and impairment charges, increasing operational uncertainty going forward.
See More
Class Action Lawsuit Filed Against Nano-X Imaging Ltd.
- Class Action Initiation: Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025, and April 17, 2026, allowing potential lead plaintiffs to apply by August 11, 2026, for compensation.
- Lawsuit Allegations: The lawsuit claims that Nano-X made false statements regarding operational efficiency and product demand, resulting in significant investor losses when the truth emerged, highlighting a misalignment between production capabilities and market needs.
- Cost Structure: Investors joining the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, which lowers the barrier for affected investors to participate in the lawsuit.
- Firm's Reputation: Rosen Law Firm is recognized for its success in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resourcefulness in handling such cases.
See More
Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
- Class Action Initiation: Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey, covering securities transactions from March 31, 2025, to April 17, 2026, seeking damages for violations of federal securities laws by company executives.
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a Q4 net loss of $33.4 million, including a $17.5 million impairment charge, highlighting significant issues in production efficiency and cost management.
- Stock Price Plunge: Following the earnings release, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting market pessimism regarding the company's future prospects.
- Executive Changes: The resignation of CFO Ran Daniel effective July 31, 2026, indicates management instability as the company navigates operational challenges and restructuring efforts.
See More
Class Action Lawsuit Reminder Against Nano-X Imaging Ltd.
- Class Action Notification: The Schall Law Firm is reminding investors of a class action lawsuit against Nano-X Imaging Ltd. for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between March 31, 2025, and April 17, 2026.
- False Statement Allegations: The complaint alleges that Nano-X made false and misleading statements regarding product demand and operational efficiency, resulting in significant investor losses once the truth was revealed.
- Cash Flow Issues: The company is experiencing increased cash burn due to misalignment with customer demands, exacerbating its financial difficulties and negatively impacting market reputation and investor confidence.
- Legal Consultation Opportunity: The Schall Law Firm encourages affected investors to contact them before August 11, 2026, to participate in the lawsuit and seek compensation for losses, emphasizing that investors are not represented until the class is certified.
See More
Nano-X Imaging Under Investigation Following Significant Losses and Stock Drop
- Financial Loss Disclosure: On April 20, 2026, Nano-X Imaging reported a net loss of $33.4 million in its Q4 2025 financial results, primarily due to a $17.5 million impairment charge related to restructuring at its Korean chip manufacturing facility, highlighting significant financial strain and operational challenges.
- Executive Departure Impact: The announcement of the CFO's resignation raises concerns about the company's future financial management capabilities, potentially undermining investor confidence and adversely affecting stock performance.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price plummeted by $0.69, or 24.4%, closing at $2.16 per share, reflecting a strong investor reaction to the company's financial health, which may lead to more investors seeking legal recourse.
- Legal Investigation Initiated: The Law Offices of Howard G. Smith have announced an investigation into potential violations of securities laws by Nano-X, aiming to provide legal support for affected investors, indicating that the company faces increasing legal risks that could exacerbate market uncertainty.
See More
Reminder of Shareholder Class Action Lawsuits
- ADMA Lawsuit Details: The class action lawsuit against ADMA Biologics, Inc. alleges that the company made materially false or misleading statements between August 9, 2024, and March 25, 2026, leading to investor losses, with a deadline of August 10, 2026, for investors to apply as lead plaintiffs to protect their rights.
- Erasca Case Overview: The shareholder class action against Erasca, Inc. claims that the company failed to disclose material facts related to ERAS-0015 from January 14, 2025, to April 26, 2026, with a similar deadline of August 10, 2026, for investors to seek lead plaintiff status for legal recourse.
- Nano-X Litigation Insights: The lawsuit against Nano-X Imaging Ltd. alleges false statements regarding operational efficiency and cash burn from March 31, 2025, to April 17, 2026, with a deadline of August 11, 2026, for investors to apply as lead plaintiffs to safeguard their interests.
- Law Firm Credentials: Holzer & Holzer, LLC, recognized as a top-rated securities litigation firm from 2021 to 2025, focuses on vigorous representation of shareholders, having recovered hundreds of millions for victims of fraud and corporate misconduct since its inception in 2000.
See More
